Increased expression of CD16, CD69, and very late antigen-1 on blood monocytes in active sarcoidosis

Chest

Volumn 134, Issue 5, 2008, Pages 1001-1008

  Heron, Michiel ^a   Grutters, Jan C ^a   Van Velzen Blad, Heleen ^a   Veltkamp, Marcel ^a   Claessen, Anke M E ^a   Van Den Bosch, Jules M M ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Flow cytometry; Monocyte activation; Sarcoidosis; Surface molecules

Indexed keywords

CD16 ANTIGEN; CD69 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE; UNCLASSIFIED DRUG; VERY LATE ANTIGEN 1;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; SARCOIDOSIS;

EID: 55849120506     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-0443     Document Type: Article

References (34)

1. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981; 305:429-434
2. Pierce TB, Margolis M, Razzuk MA. Sarcoidosis: still a mystery? Proc (Bayl Univ Med Cent) 2001; 14:8-12
3. Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007; 81:584-592
4. Caruso A, Licenziati S, Corulli M, et al. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry 1997; 27:71-76
5. de Fougerolles AR, Sprague AG, Nickerson-Nutter CL, et al. Regulation of inflammation by collagen-binding integrins α1β1 and α2β1 in models of hypersensitivity and arthritis. J Clin Invest 2000; 105:721-729
6. de Fougerolles AR, Chi-Rosso G, Bajardi A, et al. Global expression analysis of extracellular matrix-integrin interactions in monocytes. Immunity 2000; 13:749-758
7. Ben-Horin S, Bank I. The role of very late antigen-1 in immune-mediated inflammation. Clin Immunol 2004; 113:119-129
8. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol 1990; 8:365-400
9. Saltini C, Hemler ME, Crystal RG. T lymphocytes compartmentalized on the epithelial surface of the lower respiratory tract express the very late activation antigen complex VLA-1. Clin Immunol Immunopathol 1988; 46:221-233
10. Wahlstrom J, Berlin M, Skold CM, et al. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax 1999; 54:339-346
11. Striz I, Wang YM, Kalaycioglu O, et al. Expression of alveolar macrophage adhesion molecules in pulmonary sarcoidosis. Chest 1992; 102:882-886
12. Liote F, Boval-Boizard B, Weill D, et al. Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression, and cytokine release. Clin Exp Immunol 1996; 106:13-19
13. Okamoto H, Mizuno K, Horio T. Circulating CD14+ CD16+ monocytes are expanded in sarcoidosis patients. J Dermatol 2003; 30:503-509
14. Grutters JC, Beirne PA, Claessen AME, et al. Strong increase of proinflammatory blood monocytes in active pulmonary sarcoidosis 2004: 355s.
15. Grutters JC, Fellrath JM, Mulder L, et al. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation. Chest 2003; 124:186-195
16. Weinstock JV. The significance of angiotensin I converting enzyme in granulomatous inflammation: functions of ACE in granulomas. Sarcoidosis 1986; 3:19-26
17. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis: American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:149-173
18. Kruit A, Grutters JC, Gerritsen WB, et al. ACE I/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis. Respir Med 2007; 101:510-515
19. Ehrchen J, Steinmuller L, Barczyk K, et al. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 2007; 109:1265-1274
20. Pforte A, Brunner A, Gais P, et al. Concomitant modulation of serum-soluble interleukin-2 receptor and alveolar macrophage interleukin-2 receptor in sarcoidosis. Am Rev Respir Dis 1993; 147:717-722
21. Krieglstein CF, Cerwinka WH, Sprague AG, et al. Collagen-binding integrin alpha1beta1 regulates intestinal inflammation in experimental colitis. J Clin Invest 2002; 110:1773-1782
22. Abraham WM, Ahmed A, Serebriakov I, et al. A monoclonal antibody to alpha1beta1 blocks antigen-induced airway responses in sheep. Am J Respir Crit Care Med 2004; 169:97-104
23. Ianaro A, Cicala C, Calignano A, et al. Anti-very late antigen-1 monoclonal antibody modulates the development of secondary lesion and T-cell response in experimental arthritis. Lab Invest 2000; 80:73-80
24. Prasse A, Georges CG, Biller H, et al. Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells. Clin Exp Immunol 2000; 122:241-248
25. Rubio MA, Sotillos M, Jochems G, et al. Monocyte activation: rapid induction of α1/β1 (VLA-1) integrin expression by lipopolysaccharide and interferon-γ. Eur J Immunol 1995; 25:2701-2705
26. Ziegler-Heitbrock HW. Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. Immunol Today 1996; 17:424-428
27. Pulliam L, Gascon R, Stubblebine M, et al. Unique monocyte subset in patients with AIDS dementia. Lancet 1997; 349:692-695
28. Belge KU, Dayyani F, Horelt A, et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 2002; 168:3536-3542
29. Landsman L, Varol C, Jung S. Distinct differentiation potential of blood monocyte subsets in the lung. J Immunol 2007; 178:2000-2007
30. De Maria R, Cifone MG, Trotta R, et al. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med 1994; 180:1999-2004
31. De Rose V, Trentin L, Crivellari MT, et al. Release of prostaglandin E2 and leukotriene B4 by alveolar macrophages from patients with sarcoidosis. Thorax 1997; 52:76-83
32. Pueringer RJ, Schwartz DA, Dayton CS, et al. The relationship between alveolar macrophage TNF, IL-1, and PGE2 release, alveolitis, and disease severity in sarcoidosis. Chest 1993; 103:832-838
33. Wilsher ML, Fergusson W, Milne D, et al. Exhaled nitric oxide in sarcoidosis. Thorax 2005; 60:967-970
34. Judson MA, Baughman RP, Teirstein AS, et al. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument; ACCESS Research Group: A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:75-86